Centene Corporation (CNC)

Over the past six months, Centene's stock experienced several notable events and trends. In February 2026, Centene reported its Q4 2025 and full year 2025 earnings, with a GAAP diluted loss per share of $(13.53) for the full year 2025 and an adjusted diluted EPS of $2.08. Remarks by CEO Sarah London at the Barclays 28th Annual Global Healthcare Conference in March 2026 led to a significant drop in Centene's share price due to concerns about potential losses in ACA membership. In April 2026, Centene reported strong first-quarter 2026 results, with EPS and revenues exceeding analyst expectations, and increased its 2026 GAAP Diluted EPS Guidance to greater than $2.37. Centene's stock experienced a significant reduction in share price in the past year, reaching a low of around $25 in August 2025, before rising to around $47 in January 2026, and as of May 8, 2026, the stock price was $55.96.

Centene's business exhibits some seasonality, particularly in its government-sponsored healthcare programs. Centene expects some attrition in its ACA membership throughout the year after initial sign-ups and payments, with a return to more normal seasonality in this product line. Medicare Advantage enrollment is projected to grow, with roughly 10,000 baby boomers turning 65 every day. Centene's Q1 2026 results noted a lighter flu season than originally forecast and a slight utilization benefit from weather events. The company experiences membership performance fluctuations during annual enrollment periods in Medicare Advantage and Prescription Drug Plans. Historically, Centene Corp. stock has, on average, risen by 19.1% over a 52-week period based on the past 24 years of performance.

Centene Corporation is an American for-profit healthcare company operating as a managed care organization, primarily serving as an intermediary for government-sponsored and privately insured healthcare programs. The company is headquartered in Clayton, Missouri, and is a component of the S&P 500, operating within the Healthcare sector and the Medical - Healthcare Plans industry. Centene's major products and services are delivered through several segments, including Medicaid, ACA Health Insurance Marketplace (Ambetter), Medicare, Commercial Insurance, and Specialty Services.

Centene Corporation has a strong geographic diversity, with operations spanning all 50 states in the U.S. It is the largest Medicaid health insurer in 30 states and holds a market leader position in major states like Florida, New York, and Texas. As of December 2025, Centene served 20 million medical members nationwide.

In the past year, Centene has received recognition for its innovation and workplace culture, while also facing ongoing challenges related to past practices. Centene was recognized as one of America's Most Innovative Companies by Fortune for the third consecutive year and was named to Forbes' best employers for company culture list for the second year in a row. For the 2025 plan year, Centene achieved National Committee for Quality Assurance (NCQA) accreditation in 94% of the states where it operates health plans, and approximately 55% of its Medicare Advantage membership was enrolled in plans rated 3.5 stars or higher. Between June 2021 and January 2022, Centene agreed to settlements with several states totaling over $191 million to resolve allegations of overpayments to its pharmacy benefit manager subsidiary, Envolve, from state Medicaid programs.

Centene Corporation's ownership is broadly distributed, with a significant presence of institutional investors. As of May 2026, Centene has 905 institutional owners and shareholders holding a total of 474,816,351 shares, with 93.63% owned by institutional investors and hedge funds as of August 3, 2025. Major institutional owners include Vanguard Group Inc., BlackRock, Inc., and AQR Capital Management Llc. Insider ownership stands at 3.48% (17.13 million shares).